Intranasal inserts to treat chronic respiratory and CNS diseases
A platform of long-acting intranasal solid-dosage forms for local and Nose-To-Brain drug delivery
About us
Dianosic is clinical-stage biotech designing transformative long-acting resorbable intranasal solid-dosage forms to overcome the delivery challenges of current chronic respiratory and CNS therapies.ch
Our Science
Dianosic develops a platform of cutting-edge intranasal solid dosage forms. It enables sustained local and Nose-To-Brain drug delivery based on a proprietary know-how in long-acting, low-dose, resorbable polymer inserts.
Pipeline
One platform. Three programs:
DIA01-R in Chronic Allergic Rhinitis
DIA02-S in Chronic Rhinosinusitis
DIA03-N2BS in refractory Schizophrenia
Partner with us
Dianosic de-risks formulation, preclinical in vivo activities and ensures Clinical readiness. We integrate your API into our proprietary intranasal solid dosage form and also provide access to our internal programs.
